The main economic indicators in November were better than expected
The Information Office of the State Council held a press conference on the morning of the 16th. The National Bureau of statistics introduced the operation of China's national economy in November. Data shows that the main economic indicators of the month were better than expected, and the national economy maintained a steady and progressive trend. In terms of industry, in November, the added value of industries above designated size increased by 6.2% year-on-year, 1.5 percentage points higher than that of last month, and the added value of emerging industries such as high-tech manufacturing industry and equipment manufacturing industry continued to accelerate. From the perspective of investment, from January to November, China's fixed asset investment was 53371.8 billion yuan, up 5.2% year on year, the growth rate was the same as that from January to October. Investment in high-tech industries continued to grow, while investment in education, culture, ecological protection, environmental governance and other short board areas grew rapidly. In terms of consumption, in November, the total retail sales of social consumer goods reached 3809.4 billion yuan, up 8.0% year-on-year, 0.8 percentage points faster than that of last month, the growth rate of market sales accelerated, and the proportion of online retail sales of physical goods continued to increase. In addition, the employment situation was generally stable. In the first 11 months, 12.79 million new jobs were created in cities and towns across the country, 116.3% of the annual target. In November, the unemployment rate of 31 cities and towns was 5.1%, which was the same as that of last month. Fu Linghui, spokesman of the National Bureau of Statistics: in November, in the face of the complex situation of significantly rising risks and challenges at home and abroad, all departments in various regions adhered to the general tone of seeking progress while maintaining stability, and promoted high-quality development with supply side structural reform as the main line. The main economic indicators were better than expected, and the national economy maintained a steady and progressive development trend.
Looking for chemical products? Let suppliers reach out to you!
2026-05-21
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The operating conditions of the German chemical industry have further deteriorated
-
How can we use nitrogen as fuel in various industry?
-
Nepal consumes 800 metric tons of pesticides every year
-
China's pesticide and fertilizer market seeks biological alternatives
-
China丨“Top 50 Exporting Companies of China Agrochemical in Year 2021” List Released
-
CBI faces up to triple risks at home and abroad, will focus on five areas
-
Three Capabilities Activates New Kinetic Energy of Future Industry.
-
Rising Global Demand for Shrimp Products will Boost Indian Seafood Export Earnings
-
The economic performance of the rubber industry has improved in May
-
The pharmaceutical industry will undergo four major changes
Recommend Reading
-
Clariant and Shanghai Electric Partner to Advance Biomass-Based Green Methanol in China
-
Sekisui Chemical Announces Sixth Plant in India
-
Zhongke Electric to Invest $1.1 Billion in Lithium-Ion Battery Anode Material Plant in Oman
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
Toray Establishes Water Technology Center in Saudi Arabia
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Premium Global Chemical Sourcing Requests (18–22 Aug 2025)
-
Air Liquide to Acquire Korea’s DIG Airgas for €2.85 Billion
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal